Results 231 to 240 of about 967,275 (342)

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis.

JAMA Netw Open
Skaarup KG, Lassen MCH, Hosseini K, Johansen ND, Loiacono MM, Harris RC, Samson SI, Palmu AA, McConeghy K, Gravenstein S, Vardeny O, Claggett B, Solomon SD, Martinón-Torres F, Biering-Sørensen T.   +14 more
europepmc   +1 more source

A Monoclonal Antibody ELISA-Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines. [PDF]

Influenza Other Respir Viruses
Odin M, Schmeisser F, Soto J, Weir JP.
europepmc   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial. [PDF]

J Infect Dis
Daulagala P, Leung YWY, Luk LLH, Ho F, Chu SHN, Lin J, Cheng SMS, Leung NHL, Eichelberger MC, Peiris M, Iuliano AD, Thompson MG, Cowling BJ, Yen HL.   +13 more
europepmc   +1 more source

[Influenza vaccine and influenza vaccination].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1993
L, Flugsrud, H, Nøkleby
openaire   +1 more source

Understanding the Epidemiology of Pertussis in Denmark

Acta Paediatrica, EarlyView.
Tine Dalby, Aoife Ronayne, Peter Henrik Andersen   +2 more
wiley   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source

Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines. [PDF]

NPJ Vaccines
Hernandez-Davies J, Felgner J, Strahsburger E, Laster J, Jain A, Yates T, Silzel E, Assis R, Nakajima R, Jasinskas A, Yeromin A, Pone EJ, Jan S, de la Maza LM, Liang L, Felgner P, Wagar LE, Gregory AE, Davies DH.   +18 more
europepmc   +1 more source

Influenza Vaccination Among Individuals With Type 1 Diabetes in Denmark: Coverage, Persistence, and Determinants, 2015–2022

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate influenza vaccination coverage (IVC) and persistence with annual influenza vaccination among individuals with type 1 diabetes in Denmark and to identify clinical, demographic, and socioeconomic factors associated with vaccination status.
Vithiya Karunakaran, Ida Borreby Pedersen, Astrid Hjelholt, Mads Kjølby, Esben Thyssen Vestergaard, Ole Frøbert, Anders Aasted Isaksen, Kurt Kristensen   +7 more
wiley   +1 more source

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source